Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Short SellingSee which listed companies have disclosed short interest
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Bruxelles stejler over UPM's og Sappis papirtransaktion

UPMAnalyst Comment27.08.2026, 07.00
Antti ViljakainenHead of Research
Discuss

Summary

  • Europa-Kommissionen har udstedt en klagepunktsmeddelelse vedrørende UPM's og Sappis planlagte joint venture inden for grafisk papir, som er en del af en dybdegående fusionsundersøgelse.
  • Nyheden påvirker ikke vores estimater, da transaktionen ikke er indregnet på grund af usikkerhed omkring konkurrencemyndighedsprocessen.
  • UPM og Sappi vil gennemgå og svare på klagepunktsmeddelelsen, og der er mulighed for, at Kommissionen kan kræve indrømmelser for at godkende fusionen.
  • Transaktionen vurderes mildt positivt for UPM, da den kan frigøre selskabet fra en krympende forretningsdel, men dens indvirkning på aktiekursen anses for begrænset.

Dette indhold er genereret af AI. Du kan give feedback om det på Inderes forum.

Automatisk oversættelse: Oprindeligt udgivet på finsk 27.8.2026, 05.00 GMT. Giv feedback her.

UPM meddelt onsdag, at Europa-Kommissionen har udsendt en meddelelse om indsigelser (statement of objections) vedrørende det planlagte joint venture inden for grafisk papir mellem selskabet og Sappi. Bloomberg bragte også nyheden om sagen tirsdag. Meddelelsen om indsigelser er en normal fase i Kommissionens dybtgående fusionskontrol, hvor den fremlægger nærmere oplysninger om sine foreløbige betænkeligheder. Nyheden kom ikke som en overraskelse for os, da strukturændringer i branchen traditionelt har krævet grundige overvejelser fra myndighedernes side, og selskabets samlede markedsandele er lokalt høje i Europa. Meddelelsen giver ikke anledning til ændringer i vores estimater, da vi indtil videre ikke har inkluderet aftalen i vores tal på grund af usikkerheden omkring konkurrencemyndighedsprocessen.

UPM og Sappi vil gennemgå meddelelsen om indsigelser og svare på den i due course. Vi har tidligere vurderet, at EU-Kommissionens fase II-undersøgelse i det mindste øger sandsynligheden for, at selskaberne bliver nødt til at foretage indrømmelser for at få godkendt fusionen. Vi anser det fortsat for muligt, at Kommissionen enten kan godkende eller afvise aftalen. Vi har set mildt positivt på aftalen for selskabets vedkommende, da den ville frigøre koncernen fra direkte ejerskab af en strukturelt faldende forretningsvirksomheid. Vi mener dog ikke, at aftalens indvirkning på UPM's aktie er særlig stor, da værdien af papirforretningsområderne er begrænset i forhold til UPM's samlede virksomhedsværdi.

UPM-Kymmene is active in the forest industry. The company currently works with the development of wood biomass and biofuel. The product portfolio is broad and includes, for example, biochemicals, printing materials, paper, and timber. The company has operations on a global level, with the largest presence around the European market. The head office is located in Helsinki.

Read more on company page

Key Estimate Figures24.07

202526e27e
Revenue9,780.09,421.510,287.5
growth-%-5.4 %-3.7 %9.2 %
EBIT (adj.)921.0962.61,272.3
EBIT-% (adj.)9.4 %10.2 %12.4 %
EPS (adj.)1.331.361.82
Dividend1.501.501.50
Dividend %6.1 %6.1 %6.1 %
P/E (adj.)18.618.113.5
EV/EBITDA12.411.28.7

Forum discussions

OP’s views on UPM in Zijoittaja’s post. Target down 50c to €28.0 & Buy. Wisa cleaned out from the above figures, and its value is €0.60–0.72...
yesterday
by Opa
7
New pulp mills haven’t been called biorefineries, but bioproduct mills
yesterday
by Lehtilamarkus 140355
3
Ponsse initiates change negotiations, over 1,100 employees may face temporary layoffs. “The company justifies the change negotiations with a...
yesterday
by Yoda
6
A biorefinery can mean just about anything. After all, even new pulp mills have been called biorefineries. Leuna is a chemical plant and doesn...
yesterday
by Simo Hijoittaja
4
In my view, beating a 10% required return would be enough for a good performance here. It’s still difficult to assess the total capital tied...
10/19/2026, 6:12 PM
by mardi
5
The total investment in Leuna ended up being 1,300 MEUR, but 373 MEUR of that was already written down in 2025. Was this included in the calculation...
10/19/2026, 4:51 PM
by Logitech
3
The opening of Leuna was indeed celebrated late last week. I’ve continued to wonder how UPM calls Leuna the world’s first commercial-scale biorefinery...
10/19/2026, 11:23 AM
by mardi
7